whistle blower claims 20%+ of NY medicaid recipients not legally eligible for benefits

Patricia Monks stands for a photo Thursday, May 15, 2015, at the Times Union in Colonie, N.Y. She was fired from her job as an auditor of the state’s Medicaid program after she raised questions about improprieties in how the work was being done. (Will Waldron/Times Union) Photo: WW

Fired auditors say Medicaid errors remain issue at New York Health Department

http://www.timesunion.com/news/article/Fired-auditors-say-Medicaid-errors-remain-issue-6283448.php

The state terminated its contract with the Research Foundation in 2010, a year after the U.S. Attorneys office in Albany launched its investigation of the workers’ allegations. Five months ago, the civil claim filed by Monks and her colleagues ended with the Research Foundation agreeing to pay $3.75 million to settle the case. For its part, the state Health Department admitted no wrongdoing and was not listed as a defendant, but the Health Department is referenced more than 30 times in the 15-page complaint, which casts the DOH as a co-conspirator with the Research Foundation.

“CDHS got a bum rap,” Monks said. “They took the heat for the Department of Health.”

James Ryan, who quit the unit not long after Monks was fired, was one of the fivewho filed the civil complaint and split more than $800,000, which was their share of the settlement. Ryan, 65, who like Monks was also a longtime state worker, said federal regulators who were monitoring New York’s Medicaid program “were not happy” about their lack of access to information. He said the state’s error rate for Medicaid recipients was higher than 20 percent and the Health Department was “bound and determined to report five percent.”

In a statement Friday, a Health Department spokesperson said: “The NYS DOH was not a party to the qui tam lawsuit. The SUNY Research Foundation was and settled the matter with the federal government. There has been no action brought against NYS DOH alleging any wrongdoing.”

The federal case was not the only False Claims Act case targeting New York’s Medicaid system.

The same year that Monks and her colleagues filed their claim, five state Health Department workers, including a pharmacist, a nurse and a Medicaid fraud investigator, filed a second complaint in U.S. District Court outlining allegations of fraud against Computer Sciences Corporation, a Nevada company that ran New York’s Medicaid management system since 1986, according to court records.

The claim against CSC said the company, by virture of its contract with New York, “accepted the responsibility to screen out fraudulent claims by recipients and providers.”

“During the course of their employment with the New York state Department of Health, relators have uncovered multitudinous instances in which Medicaid benefits were paid to residents of other states, deceased individuals, incarcerated individuals, or to individuals classified as ‘undomiciled’ or using bogus addresses or with invalid social security numbers,” states the complaint, which was filed under seal in July 2010.

The case remained sealed until last October, when a federal judge ordered it opened two days after the U.S. Attorney’s office notified the court that it would not pursue a fraud case against CSC.

A spokesman for U.S. Attorney Richard S. Hartunian declined comment, noting the civil case against CSC remains open. Federal prosecutors told the court they are reserving their right to pursue a case at a later time.

Harvey Brody, one of the claimants against CSC, is an investigator for the state Office of Medicaid Inspector General. For the past three years, he said, the state has paid him a salary even though he has not been allowed to return to work, has no duties, and still receives favorable job reviews annually.

“They were afraid of me and the other relators (complainants) because we found a pattern of false claims,” Brody said. “We had actual evidence, documents … showing that payments were made to people that didn’t receive services. We think it was about $970 million over roughly a three-year period.”

But their federal complaint lost footing after the U.S. Attorney’s office declined to pursue the case, and their former attorney, state Assemblyman Phil Steck, filed papers asking a federal judge to dismiss the lawsuit.

“We don’t have access to the government’s investigation, so I can’t tell you whether the allegations were completely false or just couldn’t be substantiated,” Steck said. “I think from a lawyer’s point of view sometimes you can have enough probable cause to file a lawsuit, but … it turns out you come to the realization that the case cannot be proven.”

Steve Sumner, an attorney in Dallas, represented CSC in the case and said the allegations made by Brody and his colleagues were baseless.

“Those types of allegations were just off-the-charts inaccurate,” Sumner said. “We were in real close contact with the U.S. Attorneys and DOH investigators, and in fact conducted some of the investigation with the government.”

Patricia Pafundi, a Health Department pharmacist who was a complainant in the federal claim against CSC, said that in her work checking prescriptions for accuracy she uncovered numerous instances of fraud, including claims paid to deceased individuals, ineligible recipients, residents of other countries and to pay for forged prescriptions. Abusing the Medicaid system is “like stealing candy from a baby,” she said.

Pafundi said she reported the problems to everyone from former Senate Majority Leader Joseph L. Bruno to U.S. Sen. Kirsten Gillibrand.

“I think that was the most irritating thing is you would report these and nothing would get done and you continue to see it over and over again,” she said. “The reality is every dollar that’s stolen is another dollar that can’t be spent on people who legitimately earned and need health care. … It’s a shame that people aren’t concerned enough to stop what’s going on.”

“It’s a shame too that Heroin has made us a family”

Portland residents march for heroin abuse awareness

http://www.whas11.com/story/news/local/2015/05/23/portland-residents-march-for-heroin-abuse-awareness/27865161/

LOUISVILLE, Ky. (WHAS11) – Walking the streets of Portland there are a sea of faces affected by heroin marching together in a poignant display of those left behind.

“He was my best friend. He was the love of my life and he’s not just a number. He’s a person,” Jessica Biszmaier said.

Biszmaier lost her boyfriend Donald Jackson to heroin. She now has to raise their 3-year-old daughter Emilee on her own.

“I have to look at her every day and see him and it sucks,” she said. “I just told her daddy’s up there with the angels and he’s watching over us. She loved him very much.”

Jackson’s mother Lauretta buried her son just one month ago.

Standing alongside Jessica, she’s joining a very personal fight to raise awareness about heroin abuse. They’re begging neighbors not to ignore the warning signs.

“If you’re looking at your neighbor and you’re seeing 50 to 60 people coming in and out, you know what’s going on. Make a call,” she said. “It’s a bad epidemic down here and no one should ever have to bury their child. Donald was my baby – my youngest and you shouldn’t have to do that.”

The body of 4-month-old Natallya Rich, missing for several days, was found in her grandmother’s basement.VPC

Jessica and Lauretta’s wounds are still fresh but they’re finding comfort walking alongside others who understand the depth of their grief. Almost everyone who attended the event has lost a loved one to heroin abuse.

“It helps because we all love each other in some kind of way or we loved him or we loved whoever is lost by this,” Biszmaier said.

“It’s a shame too that this drug has made us a family but it’s a family that can go strong and help each other,” Biszmaier’s sister Ashley said.

With every sign, step and honk they hope to raise awareness and remember the many lives gone too soon.

Last year the Center for Disease Control and Prevention released a report showing in just two years, between 2010 and 2012, deaths from heroin overdoses doubled in the U.S.

Here in Kentuckiana, the extremely addictive drug remains a major problems local officials continue to evaluate.

It is all about the addicts… everyone else is on their own ?

How Pharmacists Restrict Access To Pain Medications

http://www.wkrg.com/story/29128410/how-pharmacists-restrict-access-to-pain-medications

When it comes to keeping pain medications out of the hands of addicts, pharmacies have several methods and restrictions.

Addiction to pain medication is becoming a bigger problem each year.

“We definitely see a lot more pain medication prescriptions now than we did 20 years ago,” says Karen Kight.

Pharmacist and owner of Medicap Pharmacy, Karen Kight sees the problem and, like all pharmacists, has ways to prevent pain meds from getting in the hands of addicts. One tool is the Prescription Drug Monitoring Report.

“Shows the pharmacies where you’ve had prescriptions filled, the doctors who wrote them, and even whether or not they were put on your insurance or you paid cash for them,” says Kight.

Being a small town pharmacy also works in their favor.

“We know our patients, so most of the time we know their diagnosis, why they are on chronic pain medication.”

But they do occasionally get strangers in here which is when they can use the monitoring report, check for ID and ask some more questions.

As another precautionary measure, Karen and her staff don’t normally keep pain medication readily available on the shelves. They only order it for their patients on an as-needed basis.

“We were burglarized a couple years ago.”

Lots of precautions against a problem that may be out of her hands.

“I definitely think it is going to become a bigger problem, prescription drug abuse is definitely on the rise.”

Painful Truth… Pained lives matter !

https://youtu.be/WVAgBoBJUzY

Ken McKim.. first in new series of podcasts

nogovernor

http://www.spreaker.com/user/dontpunishpain/special-guest-steve-ariens

I have had the privilege of being Ken Mc Kim’s first guest on his new podcast series..   https://www.facebook.com/ken.mckim.1?fref=nf

I will be available soon for autographs  🙂

 

CVS finds new way to deny care under their Silver Scripts PDP Medicare Part D.

Community CCRx - 2012 Part D OptionsCommunity CCRx Part D no longer offering Part D plans

There are literally dozens of Part D plans offered in most States and although no single plan is the best for everyone, some plans will be a huge benefit for Medicare beneficiaries on certain Medications.

Community CCRx members were transitioned to SilverScript Part D plans in January 2013. SiverScript has been offering Part D Plans since 2006 and have over 4 million members.

It would seem that either employees of CVS Health/Silver Scripts have not been trained well enough to find anything in their computer system… or CVS Health has DUMPED a large portion of important forms/paperwork that was part of the CCRx database.

I called Silver Scripts today, to get a vacation over-ride for two medication for my wife (Barb)… I was first told that there was no POA form on file for me to speak to them.. although that form was submitted and always been found since Jan 2006.

After letting them talk to Barb to give them permission to talk to me about her medications.. they told me would only OK a 30 day supply as a vacation over-ride.. while they provided a 90 days supply over-ride last year.. keep in mind the Rx would be due to be refilled in abt a week.. and she has been taking it since 2006/2007.

I asked to speak to a supervisor… got off this conversation with seemingly the vacation over-ride in placed.. called the pharmacy and one was authorized but the second – a expensive generic – DENIED… the Pharmacist tried billing three difference NDC numbers.. including the one that they paid for 3 weeks ago for a 30 day supply.

Another call to Silver Scripts… the person this time tells me that the generic is not on the formulary but the brand name was .. so I called the Pharmacists back and he tried to bill for the brand name… DENIED….

Another call to Silver Scripts… of course different person this time.. she is confused why my wife has been prescribed the same medication TWICE – brand name and generic.. another long explanation as to why that was .. and to ignore the attempt to charge the brand name..

Then she told me that the generic needed a PRIOR AUTHORIZATION… and there was none on record… but.. couldn’t explain why they had been paying for it since I got the PA for back in 2006 or 2007 and why I was told when CCRx converted to Silver Scripts I verified that the PA would follow and was assured that it was good for TEN YEARS …

Simple solution – per her – just get your doctor to fill out a new PA.. keep in might this all started over a vacation over-ride request and Monday is a holiday and before we could get an appt and Barb would be out of medication… we would be hundreds of miles away.. This is for a controlled med and everyone knows how happy Pharmacists are about filling out of state Rxs for controlled substances..

This woman had no idea that Silver Scripts had acquired CCRx years ago… she claimed that the PA was probably with a different PDP..

So has CVS Health/Silver Scripts indiscriminately purged necessary forms from their system from the pts they acquired from CCRx .. or is this just another “save a buck” ploy to help make sure that Merlo gets his bonus or help make sure that they have the 10 billion to buy Omnicare ?

I ran into another problem with Silver Scripts last year in getting a vacation over-ride on this same medication for Barb and the Silver Scripts employee told me at the time… that “I would have to get it filled at CVS.. IF THEY APPROVED IT “..  We don’t use CVS..!!  After I convinced her that she was wrong and I got the approval and verified with the pharmacy that they got a authorization to fill and get paid…

I went to www.cms.gov and file a complaint about Silver Scripts attempting to violate my wife’s freedom of choice… as provided for in Medicare… within a hour a got a response from CMS and shortly their after I got a call from a supervisor from Silver Scripts.. who gave me her direct phone number… which I have in my trusty IPhone … and who I will be talking to on Tues …  If she can’t get this situation resolved..

To sum it up… a disabled Medicare pt… covered by ADA…. being denied medication she has been on for years… that without it will adversely affect her quality of life…  how many emails/complaints/phone calls… let me count the ways ….

 

Is the DEA “NOT COMFORTABLE” with the number of Heroin death increases ?

Nationally, the number of deaths involving heroin more than tripled to 8,260 overdose deaths in 2013, from 2,402 deaths in 2007, according to the U.

DEA report: Heroin use growing faster than any other illicit drug; overdose deaths highest in a decade

http://www.providencejournal.com/article/20150522/NEWS/150529638

Nationally, the number of deaths involving heroin more than tripled to 8,260 overdose deaths in 2013, from 2,402 deaths in 2007, according to the U.S. Centers for Disease Control and Prevention.

PROVIDENCE, R.I. — The National Heroin Threat Assessment released Friday by the U.S. Drug Enforcement Administrations shows heroin use and availability are on the rise, with more heroin-related deaths than at any time in the last decade.

Nationally, the number of deaths involving heroin more than tripled to 8,260 overdose deaths in 2013, from 2,402 deaths in 2007, according to the U.S. Centers for Disease Control and Prevention. During the same period, the population of heroin users nearly doubled, to 289,000, in 2013, from 161,000 in 2007, according to the Substance Abuse and Mental Health Services Administration (SAMHSA).

In Rhode Island, overdose deaths have grown by more than 73 percent during the last five years, to 239 deaths in 2014, according to the state health department. The number of overdose deaths involving heroin were not available.

Although fewer people presently use heroin than other illicit drugs, the heroin user population is growing at a faster rate than any other drug of abuse, the DEA said in a statement.

The higher demand for heroin is partly driven by an increase in controlled prescription drug-abuse over the past decade. A recent SAMHSA study found that four out of five recent new heroin users had previously abused prescription pain relievers. Heroin is now higher in purity, less expensive, and often easier to obtain than illegal prescription painkillers and is of a higher purity, so it can be smoked or snorted, thereby avoiding the stigma associated with injection, the DEA statement said. Heroin users today tend to be younger, more affluent, and more ethnically and geographically diverse than ever before.

“DEA is targeting the cartels that produce and smuggle heroin into the U.S. and organized criminals that distribute this poison,” DEA Administrator Chuck Rosenberg said. “We will continue to combat heroin trafficking to protect Americans from this severe and growing threat.”

The NHTA is based, in part, on survey responses from more than 1,100 law enforcement agencies, which were asked to identify the greatest drug threat in their areas. The majority indicated heroin as the primary drug threat.

The percentage of agencies reporting heroin as their greatest concern has steadily increased from 8 percent in 2007 to 38 percent in 2015. Heroin seizures nationwide rose 81 percent from 2010 through 2014, according to data from the the National Seizure System. During that same period, the average size of a heroin seizure more than doubled, to 1.74 kilograms.

DEA National Heroin Threat Assessment Summary (PDF)

son broke into her medicine cabinet in 2013 and accidentally overdosed on her accumulated stockpile of amphetamines, benzodiazepines and morphine.

Woman Sues Walgreens, Claims Company Is Responsible for Son’s Overdose and Her Attempted Suicide

http://patch.com/illinois/deerfield/woman-sues-walgreens-claims-company-responsible-sons-overdose-and-her-attempted-suicide

A woman is suing Walgreens, claiming the Deerfield-based pharmacy giant prescribed excessive amounts of narcotics that led to the accidental overdose death or her son and her suicide attempt the following day.

Donna Soltis cites negligent supervision and training, general negligence and negligent infliction of emotional distress in a lawsuit filed May 6 in Cook County Circuit Court against Walgreen’s, Inc.; Walgreens Pharmacy Stores numbers 4460, 5713 and 1484; unnamed pharmacists in those stores; A and T Pharmacy Inc.; and unknown pharmacists there, according to the Cook County Record. Walgreen’s is accused of doling out the medications from 2010 to 2014.

In the complaint, Soltis claims she began seeing Dr. Blaise Wolfrum in 1990 and continued to be treated at his substance abuse center/pain management clinic until 2014. Wolfrum prescribed “mega quantities of controlled substances [powerful narcotics, antipsychotics] to the plaintiff,” the suit states.

The suit also claims Soltis’ 31-year-old son broke into her medicine cabinet in 2013 and accidentally overdosed on her accumulated stockpile of amphetamines, benzodiazepines and morphine. Soltis then tried to kill herself with the excess pills the following day, despondent over her son’s death.

Soltis seeks unspecified damages, plus costs, to be determined by the court.

Bureaucrats always have a hidden agenda

SRAcrystalball

Being a student of our bureaucracy for several decades… they never do anything directly… they never do something in a large way… they seemingly always have a hidden agenda behind what they are talking about here and now. The FDA has never had any authority of anything sold labeled as a “supplement”… Supplements are vitamins/minerals and other things under the label of Homeopathic items. Typically, there is little/no clinical studies behind these products…  they cannot make any claims of treating any disease state.. and you will find on the label the following statement “This statement has not been evaluated by the FDA. This product not intended to diagnose, treat, or prevent any disease ”

If MMJ/MJ was not classified as a Class I controlled substance.. it would technically be classified as a “supplement”.. Is there a hidden agenda that the FEDS have on their timetable when MJ/MMJ is going to be decriminalized and thus this move on changing the FDA’s oversight of supplements… if passed.. would automatically put MMJ/MJ under the FDA’s oversight once it is decriminalized ?  Guess who is a large contributors to political election campaigns ???   the BIG PHARMA’S …. guess who would gain the legal right to produce and sell MMJ/MJ under the FDA ?

If the FDA gets oversight of supplements… look for the FED to grant the BIG PHARMA’s the rights to start clinical trials of various fractions of MJ and get patents on those fractions.

Senators Urge Justice Department to Step Up Actions against Adulterated Supplements

http://www.naturalproductsinsider.com/blogs/sports-nutrition/2015/05/senators-urge-justice-department-to-step-up-actio.aspx

Senators Orrin Hatch (R-UT) and Martin Heinrich (D-NM) have sent a letter to newly appointed U.S. Attorney General (AG) Loretta Lynch in an effort to educate her on the severity of the negative impact and dangers adulterated products sold as dietary supplements are having on both the supplement industry and public health, and to implore her to increase Department of Justice (DOJ) investigations and enforcement actions on such products, especially those identified by FDA.

In the letter, Hatch and Heinrich welcomed the new AG and expressed their concern about blatant criminal adulteration of products masquerading as dietary supplements. They called out anabolic compounds in sports products and active pharmaceutical ingredients (APIs) in weight-loss and sexual dysfunction products as especially problematic and threatening to public health

“We strongly urge DOJ, in cooperation with FDA to prioritize the aggressive pursuit of individuals and companies that illegally manufacture and sell misbranded drug products falsely labeled as dietary supplements,” the senators wrote. “Such an approach would both incapacitate current criminal endeavors and deter new criminality.”

The senators explained to the AG that by selling adulterated products under the guise of legitimate dietary supplements, these bad actors hijack the credibility of reputable industry members and erode consumer confidence in legitimate products. “It is imperative that DOJ and FDA use all available tools to hold transgressors fully accountable for their actions,” they urged—Acting FDA Commissioner Stephen Ostroff was copied on the letter.

One of the key points of the letter was the senators’ assertions that FDA warning letters and voluntary recalls do not sufficiently deter these bad actors from engaging in repeat criminal behavior. “Some simply move on to another illegal ingredient or a new brand utilizing the same illegal ingredient,” they wrote. They assured subsequent punitive action from DOJ would have a greater impact on this criminal activity.

“On the occasions FDA and DOJ have worked together to pursue criminal cases, the results have been good,” the senators noted. “However, this constitutes a low number of cases and a low impact on criminal behavior.” In fact, based on public notifications DOJ has only taken action on a handful of cases involving supplements in the past five years, while FDA has charted more than 80 warning letters and voluntary recalls involving dietary supplement adulteration during that time period, including those involving sports performance compounds and APIs. At DOJ’s 2013 Annual Consumer Protection Summit, FDA Office Criminal Investigations (OCI) Attorney Jeffery Ebersole noted the agency had listed at least 332 dietary supplements found to contain APIs.

An INSIDER analysis of publicized DOJ actions taken in the past five years found of the 15 or so cases involving dietary supplements, most were for GMP violations; aside from these, joint FDA-DOJ actions were taken in 2013 against products containing DMAA, a stimulant FDA stated via numerous warning letters was not legal for use in supplements. One case involving sports supplements adulterated with anabolic compounds was the 2012 joint FDA-DOJ case against BodyBuilding.com, in which the defendants pleaded guilty. The most recent case brought by DOJ and FDA cooperation was the April 15, 2015 charging in federal court of Floyd Nutrition LLC with introducing misbranded drugs into interstate commerce and money laundering. The Harrisburg, PA-based company sold products as dietary supplements that actually contained the weight-loss APIs sibutramine and phenolphphthalein.

Generally, FDA staff members refer criminal matters to OCI including misdemeanor and felony prosecutions as well as ciriminal investigation requests. The cases that meet certain requirements are forwarded to DOJ for criminal enforcement action. Former FDA Supplement Division Director Dan Fabricant, now president and CEO of the Natural Products Association (NPA), explained FDA counsel decides which cases have enough evidence to move forward, and DOJ attorneys conduct a similar assessment of the evidence. “Often it’s FDA and DOJ working hand-in-hand,” Fabricant said.

In addition to injunctions and seizures, DOJ can assist FDA with compliance inspections of companies by ensuring access for inspections, such as with GMPs, when FDA has good reason to suspect entry to facilities will be challenged by the company. DOJ can also help secure search warrants if FDA has good cause to suspect it will find dangerous, illegal activities and materials upon such inspections. In some cases, DOJ will determine a grand jury investigation is warranted and issue the appropriate subpoenas.

In their letter to Lynch, the senators said more can be done. “Illicit behavior that puts the public health at risk warrants a full criminal investigation, and if appropriate, criminal charges should be aggressively pursued to punish wrongdoers appropriately while deterring those contemplating engaging in similar conduct,” they wrote.

Another key point made in the letter was their reminding Lynch the Federal Food, Drug & Cosmetic Act (FFDCA) provides strict liability misdemeanor violations. “In addition to pursuing felony convictions where appropriate, we recommend increased utilization of misdemeanor prosecutions as part of a focused-deterrence and selective targeting strategy against current and would-be transgressors,” they noted. “This approach would enable DOJ to proactively hold offenders accountable for their actions within the confines of existing resources.”

Fabricant confirmed the misdemeanor authority under FDCA is grossly underused. “The point Hatch and Heinrich make is a good one,” he added. “It is criminal to add a drug to a product and call it a supplement, so why aren’t there more misdemeanor cases being brought in situations that do not meet felony requirements?”

INSIDER reached out to DOJ for comment on the letter and DOJ activities in this area. The agency said it had received and is reviewing the letter. “Ensuring that the dietary supplements in this country are safe and have been manufactured in accordance with federal law is of critical importance to the Department of Justice,” it told INSIDER, in a statement. “The department is committed to ensuring that those who would seek to harm the health and safety of consumers are held accountable.”

The letter was good news for industry trade groups, as both the NPA and the Council for Responsible Nutrition (CRN) applauded the senators’ efforts.

Fabricant reiterated that products that contain drugs are not supplements, and commended the senators for elevating this important public health issue. “We have said for some time now that the FDA should enforce the laws currently on the books to prevent criminals from tainting our industry,” Fabricant stated. “The Natural Products Association looks forward to a collaborative dialogue with all stakeholders in order to prevent supplements masquerading as drugs from reaching consumers and ensuring people who break the law are punished. We are very grateful for the support from both Senators on this important issue, and we urge them to continue to advocate for the FDA to use all legal tools at its disposal to protect the millions of Americans who use dietary supplements every day.”

Mike Greene, vice president of government relations for CRN, said this letter addresses the needs of both consumers and responsible supplement companies. “We have no tolerance for companies manufacturing illegal steroids and falsely marketing them as dietary supplements,” he said. “We thank the senators for stepping up to the plate and hope that the Justice Department will do the same and work with FDA to rid the market of these kinds of illegal products.”

Grassley To Justice Department: Crack Down On Medicare Advantage Overbilling

Grassley To Justice Department: Crack Down On Medicare Advantage Overbilling

http://kmuw.org/post/grassley-justice-department-crack-down-medicare-advantage-overbilling

Senate Judiciary Committee Chairman Chuck Grassley has asked Attorney General Loretta Lynch to tighten scrutiny of Medicare Advantage health plans suspected of overcharging the government, saying billions of tax dollars are at risk as the popular senior care program grows.

In May 19 letters to Lynch and Andrew M. Slavitt, acting administrator of the Centers for Medicare and Medicaid Services, Grassley wanted to know what both agencies have done, together and apart, to stamp out overcharges that have plagued the privately run insurance program for years.

“Safeguards become all the more important as Medicare Advantage adds more patients and billions of dollars of hard-earned taxpayer money is at stake,” the Iowa Republican wrote.

Medicare Advantage plans have gained popularity as an alternative to the government-run Medicare program in recent years, and the plans now cover some 16 million people.

Grassley cited the Center for Public Integrity’s investigative reporting, which found that CMS made more than $70 billion what the agency itself deemed “improper” payments to Medicare Advantage plans between 2008 and 2013.

The concerns revolve around the accuracy of a billing tool called a “risk score,” which is supposed to pay insurers higher rates for taking sicker people and less for those with few medical needs.

But federal officials have struggled for years to track overspending tied to inflated risk scores. A 2009 agency study found that some plans had exaggerated how sick patients were to boost their payments, for instance. CMS also has acknowledged that faulty risk scores remain a costly problem, as the Center for Public Integrity first reported last year.

“With the reported increase in risk score gaming, and the monumental cost that the taxpayer will shoulder for such wrongdoing, it is imperative that CMS implement safeguards to reduce risk score fraud, waste and abuse. Moreover, if the reports of abuse are true, CMS should increase its auditing practices,” Grassley wrote.

Neither CMS nor the Justice Department had any immediate comment on the letters.

Grassley also cited a 2015 report by the Government Accountability Office , the watchdog arm of Congress, that found CMS “could save billions of dollars by improving the accuracy of its payments to Medicare Advantage programs.” The watchdog noted that CMS had estimated “improper payments” to Medicare Advantage plans at more than $12 billion in 2014 alone.

Grassley additionally referenced Center for Public Integrity reports on “an increasing number” of whistleblower lawsuits targeting Medicare Advantage. The suits argue that some insurance companies that offer Medicare Advantage “are allegedly engaging in billing abuse by altering patient records in order to claim patients are sicker than they actually are … . News reports indicate that some insurance companies are wrongfully claiming sicker patients, leading to inflated risk scores and reimbursements,” Grassley wrote.

Medicare Advantage often resonates with many seniors because of its low out-of-pocket costs. It’s also winning favor with some health policy wonks who argue these managed care plans can offer higher quality care than standard Medicare, which pays doctors and hospitals on a fee-for-service basis.

Medicare Advantage plans also have proven to be a formidable lobbying force in Washington able to repeatedly beat back any efforts by the government to cut payment rates, most recently in April.

At the time, Karen Ignagni, chief executive officer of America’s Health Insurance Plans, the industry’s trade group, noted: “Millions of seniors across the country have made their voices heard in Washington, and more than 340 members of Congress have stood in support of Medicare Advantage.”

But the whistleblower cases and government audits suggest that it’s far too easy for health plans to gouge the government.

Grassley asked Lynch for a “detailed explanation” of what steps the Justice Department “has taken, and is currently taking, to ensure that insurance companies are not fraudulently altering” risk scores.

Government investigations of Medicare Advantage plans rarely spill out into public view. One exception was a 2009 Justice Department lawsuit against the owners of America’s Health Choice Medical Plans Inc. in Vero Beach, Fla. The government accused the health plan of bilking Medicare out of millions of dollars by reporting “as many diagnosis codes as possible without regard to their truthfulness.”

The health plan denied the accusations. The case was settled in 2010 when the plan’s owners agreed to pay the government $22.6 million. The HMO is defunct.

At least one other Justice Department probe into whether exaggerated risk scores are jacking up costs is believed to be widening.

Humana Inc., based in Louisville, Ky., which counts more than 3 million seniors in its plans, wrote in a March Securities and Exchange Commission filing that “a number of Medicare Advantage plans, providers and vendors” have come under scrutiny.

On April 14, DaVita Healthcare Partners Inc., headquartered in Denver disclosed that Justice Department investigators had subpoenaed Medicare Advantage billing data and other records from January 2008 through the end of 2013.

Grassley asked both Justice and CMS to tell him how many risk-score fraud investigations had been conducted over the past five years and their outcome. He asked for a reply no later than June 3, 2015.

Grassley also wants to know how many risk score audits CMS has conducted, how much money was recovered and how much CMS spends attempting to collect overpayments.